Chicago, U.S.A. – 22-25 September 2001
Activity of oxapenem AM-112 as an antibiotic and as an inhibitor of Class A and C ß-lactamases
For download click following icon

Chicago, U.S.A. – 22-25 September 2001
Protection of cephalosporins by oxapenem AM-112 analogues as antibiotics and broad-spectrum ß-lactamase inhibitors
For download click following icon

Chicago, U.S.A. – 22-25 September 2001
AM-112, a novel oxapenem ß-lactamase inhibitor with unexpected synergistic activity with ceftazidime against Enterococci, including some vancomycin-resistant isolates
For download click following icon

Chicago, U.S.A. – 22-25 September 2001
Protection of ceftazidime against Class A and Class B ß-lactamases by oxapenems
For download click following icon

Chicago, U.S.A. – 22-25 September 2001
Affinity of Oxapenem AM-112 for Escherichia coli PBPs and effect upon morphology
For download click following icon

Chicago, U.S.A. – 22-25 September 2001
Oxapenem AM-112: In vivo efficacy alone and in combination with ceftazidime in animal models of infection, involving pathogens producing Class A and Class B ß-lactamases
For download click following icon

Chicago, U.S.A. – 22-25 September 2001
AM-112, a novel enhanced spectrum ß-lactamase inhibitor: Oral and parenteral pharmacokinetics, with and without ceftazidime, in rats and mice
For download click following icon

Milan, Italy – 24-27 April 2002
AM-114 (XOB): A novel, orally absorbed, inhibitor of Class A and C ß-lactamases
For download click following icon

Milan, Italy – 24-27 April 2002
AM-112 (PFOB): Chemistry and biological activity of a novel, broad spectrum, ß-lactamase inhibitor
For download click following icon

Milan, Italy – 24-27 April 2002
Oxapenems: Unexpected synergistic activity with other ß-lactams against Enterococcus spp.
For download click following icon

Milan, Italy – 24-27 April 2002
Oxapenems AM-114 (XOB): In vitro activity alone and in combination with amoxycillin of cefaclor against community-acquired respiratory tract pathogens
For download click following icon

San Diego, U.S.A. – 27-30 September 2002
Broad-spectrum ß-lactamase inhibitor AM-112: Synthesis and enhancement of the in vitro activity of ceftazidime and piperacillin
For download click following icon

San Diego, U.S.A. – 27-30 September 2002
AM-112, a novel oxapenem: kinetic and molecular modelling studies
For download click following icon

San Diego, U.S.A. – 27-30 September 2002
AM-114: Chemistry and biological activity of a novel orally adsorbed broad-spectrum oxzapenem ß-lactamase inhibitor
For download click following icon

May 2003
In vitro and in vivo activities of AM-112, a novel Oxapenem
For download click following icon

August 2003
In vitro activities of novel oxapenems, alone and combination with Ceftazidime, against Gram-positive and Gram-negative organisms
For download click following icon

August 2003
Pharmacodynamics of Ceftazidime plus Serine ß-lactamase inhibitor AM-112 against Escherichia coli containing TEM-1 and CTX-M-1 ß-lactamases
For download click following icon